nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinitapride—HTR4—adrenal cortex—polycystic ovary syndrome	0.0516	0.276	CbGeAlD
Cinitapride—HTR4—pituitary gland—polycystic ovary syndrome	0.0417	0.223	CbGeAlD
Cinitapride—HTR4—adrenal gland—polycystic ovary syndrome	0.0372	0.199	CbGeAlD
Cinitapride—HTR2A—urine—polycystic ovary syndrome	0.0212	0.113	CbGeAlD
Cinitapride—HTR2A—embryo—polycystic ovary syndrome	0.00686	0.0366	CbGeAlD
Cinitapride—HTR1A—adrenal gland—polycystic ovary syndrome	0.0068	0.0364	CbGeAlD
Cinitapride—HTR1A—endocrine gland—polycystic ovary syndrome	0.0059	0.0315	CbGeAlD
Cinitapride—HTR2A—pituitary gland—polycystic ovary syndrome	0.00454	0.0243	CbGeAlD
Cinitapride—HTR2A—adrenal gland—polycystic ovary syndrome	0.00406	0.0217	CbGeAlD
Cinitapride—HTR2A—vagina—polycystic ovary syndrome	0.00376	0.0201	CbGeAlD
Cinitapride—HTR2A—endocrine gland—polycystic ovary syndrome	0.00352	0.0188	CbGeAlD
Cinitapride—HTR1A—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000716	0.000881	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000712	0.000876	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000708	0.000871	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000698	0.000859	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000691	0.00085	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000686	0.000843	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000684	0.000842	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00068	0.000836	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—SCT—polycystic ovary syndrome	0.000679	0.000835	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000675	0.00083	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000675	0.00083	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000673	0.000827	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00067	0.000824	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000665	0.000818	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000664	0.000817	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000659	0.000811	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000657	0.000808	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000647	0.000796	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000642	0.00079	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000637	0.000783	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.000636	0.000783	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000636	0.000783	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000634	0.00078	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000632	0.000777	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000631	0.000776	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000631	0.000776	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000621	0.000764	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000618	0.000761	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000618	0.000761	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000616	0.000757	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000613	0.000754	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000613	0.000754	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000613	0.000754	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000596	0.000733	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000589	0.000725	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000587	0.000722	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000583	0.000717	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000583	0.000717	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000581	0.000715	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000574	0.000706	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000573	0.000705	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000569	0.000701	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000556	0.000685	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—INSR—polycystic ovary syndrome	0.000555	0.000683	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00055	0.000677	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000546	0.000671	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000545	0.000671	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000542	0.000667	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000541	0.000666	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000529	0.000651	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000529	0.000651	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000529	0.000651	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000528	0.000649	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00052	0.000639	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000515	0.000633	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PGR—polycystic ovary syndrome	0.000514	0.000633	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000502	0.000618	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000496	0.00061	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000495	0.000609	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000494	0.000608	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000492	0.000606	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000481	0.000591	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000478	0.000588	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000478	0.000588	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000471	0.00058	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000468	0.000576	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000468	0.000575	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000461	0.000567	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000456	0.000561	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000452	0.000556	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000449	0.000552	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000445	0.000547	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000443	0.000545	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000435	0.000535	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NPB—polycystic ovary syndrome	0.000434	0.000534	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000434	0.000533	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00043	0.000529	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000429	0.000527	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000428	0.000527	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000427	0.000525	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000425	0.000523	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000421	0.000518	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00042	0.000517	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000418	0.000515	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PRL—polycystic ovary syndrome	0.000417	0.000513	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000416	0.000511	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00041	0.000505	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000403	0.000495	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000402	0.000495	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000396	0.000487	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000395	0.000486	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000392	0.000483	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00039	0.00048	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00039	0.00048	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000387	0.000477	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000385	0.000474	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000384	0.000473	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000381	0.000469	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000376	0.000462	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NPB—polycystic ovary syndrome	0.000375	0.000461	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000374	0.00046	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000371	0.000457	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000367	0.000451	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000366	0.00045	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000363	0.000446	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000362	0.000445	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000362	0.000445	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000359	0.000442	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000354	0.000436	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00035	0.00043	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000349	0.000429	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000348	0.000428	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000343	0.000422	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000341	0.00042	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000341	0.000419	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000339	0.000417	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000339	0.000417	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000337	0.000415	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000333	0.000409	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000332	0.000408	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000329	0.000405	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000329	0.000404	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000323	0.000397	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00032	0.000393	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000316	0.000389	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000313	0.000385	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000313	0.000385	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000312	0.000383	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000301	0.000371	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000294	0.000362	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000294	0.000362	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000293	0.00036	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000291	0.000358	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—LEP—polycystic ovary syndrome	0.000288	0.000354	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000284	0.000349	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000284	0.000349	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000276	0.00034	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000269	0.000331	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000265	0.000326	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000259	0.000319	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000258	0.000318	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000258	0.000317	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000257	0.000316	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000251	0.000309	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000249	0.000306	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—POMC—polycystic ovary syndrome	0.000247	0.000304	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—INS—polycystic ovary syndrome	0.000246	0.000302	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000245	0.000301	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000242	0.000298	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000238	0.000292	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000238	0.000292	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FST—polycystic ovary syndrome	0.000236	0.000291	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000235	0.000289	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000233	0.000287	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—LHB—polycystic ovary syndrome	0.00023	0.000284	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000229	0.000282	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000226	0.000278	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000225	0.000277	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000224	0.000276	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000223	0.000275	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000223	0.000274	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000218	0.000268	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000218	0.000268	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000216	0.000266	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000215	0.000265	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000213	0.000262	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000209	0.000258	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000206	0.000253	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FST—polycystic ovary syndrome	0.000204	0.000251	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000203	0.00025	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000202	0.000249	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000202	0.000248	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000201	0.000247	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000199	0.000245	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000198	0.000243	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000195	0.000239	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000188	0.000232	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000188	0.000231	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000187	0.000231	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000187	0.00023	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000185	0.000227	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000184	0.000227	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000182	0.000224	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000178	0.000219	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000177	0.000217	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000175	0.000215	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000173	0.000213	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000173	0.000212	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000171	0.00021	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000168	0.000207	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000165	0.000203	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000164	0.000201	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000162	0.000199	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00016	0.000196	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000155	0.000191	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000153	0.000188	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000152	0.000187	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000152	0.000187	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000147	0.00018	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000145	0.000179	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000145	0.000179	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000143	0.000176	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000142	0.000174	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000141	0.000174	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000141	0.000173	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000134	0.000165	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000133	0.000164	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000133	0.000163	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000131	0.000162	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000131	0.000162	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000128	0.000157	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000127	0.000156	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000126	0.000155	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000125	0.000154	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000122	0.00015	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000122	0.00015	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000117	0.000144	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000116	0.000142	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000115	0.000141	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000115	0.000141	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000111	0.000137	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000111	0.000136	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000109	0.000134	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000109	0.000134	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IL6—polycystic ovary syndrome	0.000107	0.000132	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000101	0.000124	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.61e-05	0.000118	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	9.44e-05	0.000116	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	9.35e-05	0.000115	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	9.15e-05	0.000113	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	8.17e-05	0.0001	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	8.08e-05	9.94e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	7.91e-05	9.73e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	7.86e-05	9.67e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	7.82e-05	9.62e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	7.56e-05	9.31e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	7.56e-05	9.3e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.18e-05	8.84e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	7.06e-05	8.68e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	6.79e-05	8.36e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	6.76e-05	8.31e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	6.54e-05	8.04e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	6.53e-05	8.03e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.21e-05	7.63e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	5.78e-05	7.12e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	5e-05	6.15e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.94e-05	6.08e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.27e-05	5.25e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	3.42e-05	4.2e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	2.95e-05	3.63e-05	CbGpPWpGaD
